Liquid biopsy ELISA kit for early screening of esophageal cancer high-risk groups
A liquid biopsy, kit technology, applied in biological testing, material testing products, material analysis by observing the impact on chemical indicators, etc., can solve the problem of unsatisfactory long-term efficacy, inability to popularize gastroscopy, and expensive testing machines. and other problems, to achieve the effect of improving detection efficiency and diagnosis efficiency, facilitating screening and early detection, and high detection success rate
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0027] Example 1 Liquid biopsy ELISA kit for early screening of high-risk groups of esophageal cancer
[0028] 1. Composition of the kit
[0029] The composition of kit of the present invention is as follows:
[0030](1) A microtiter plate coated with three antigens: TVP23C, PAQR5, and NUBPL. The layout of the three antigens on the microtiter plate is as follows: figure 1 shown;
[0031] (2) Sample diluent: PBST (phosphate Tween) buffer containing 1% (W / V) BSA;
[0032] (3) Secondary antibody diluent: PBST (phosphate Tween) buffer containing 1% (W / V) BSA;
[0033] (4) Enzyme-labeled secondary antibody: horseradish peroxidase-labeled RecA protein (purchased from Invitrogen);
[0034] (5) Color-developing solution: The color-developing solution is composed of color-developing solution A and color-developing solution B, wherein, color-developing solution A is 0.02% (W / V) TMB (3,3',5,5'-tetramethyl base benzidine), the color developing solution B is 0.006% (W / V) urea peroxide...
Embodiment 2
[0064] Example 2 Analysis of the effectiveness of the kit of the present invention in the detection of esophageal cancer
[0065] The kit described in Example 1 of the present invention was used to detect the serum samples of patients with early esophageal cancer and normal people, so as to evaluate and analyze the value of the kit of the present invention for screening and diagnosis of early esophageal cancer.
[0066] sample source
[0067] Serum samples were collected from the Henan Province Esophageal Cancer Key Open Laboratory of the First Affiliated Hospital of Zhengzhou University, including 480 samples of normal human serum (control group) and 480 serum samples of patients with early-stage esophageal cancer (early-stage esophageal cancer group). 480 cases of normal human serum were collected from the healthy physical examination center of the laboratory's cooperative hospital, without any tumor-related evidence. Among the 480 normal subjects, there were 228 males and ...
PUM
Property | Measurement | Unit |
---|---|---|
concentration | aaaaa | aaaaa |
Sensitivity | aaaaa | aaaaa |
Sensitivity | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com